Genetic research with nonhuman primates: serving the needs of mankind Symposium summary and future prospects

The wide array of papers delivered at this symposium, ranging from population genetics to molecular genetics, is convincing evidence that genetic research with nonhuman primates is in full bloom. In fact, progress has been quite remarkable considering that a significant number of pedigreed colonies of nonhuman primates have been available for less than 25 years, which is hardly enough time to raise 3 generations of chimpanzees, 5 generations of baboons or 6 generations of rhesus monkeys. Were it not for these pedigreed colonies, we would not have been privileged to have this assemblage of papers on behavior, social structure, predisposition to disease and management of breeding colonies. It is indeed exciting that preliminary evidence has been obtained for major genes that play a role in susceptibility to dyslipoproteinemias in baboons, and that monoclonal antibodies and DNA markers are helping us to understand cholesterol metabolism. And thanks to computers, we can now rank animals in a colony in terms of their useful genotypes as well as their productivity. One can not help but be impressed with the commonality of humans and nonhuman primates at the structural and functional levels. For example, the major histocompatibility systems and the maternal-fetal relationships are very similar. We heard that this similarity is even more striking at the chromosomal, biochemical and DNA levels. A provocative question yet to be answered is, “what accounts for the obvious differences between humans and nonhuman primates in view of these incredible similarities?” In light of these advances, this symposium was at the cutting edge of primate genetics and the papers published in this issue of Genetica are certain to be hallmarks in the literature.     

The scientific and practical importance of trace elements

E. J. Underwood's discovery of the essentially of cobalt for ruminant animals is the classic example of the vast benefits to agricultural production of research into the nutritional significance of trace elements. The extension of this discovery, culminating in the identification of vitamin B12, resulted in similar benefits for human health, notably the conquest of pernicious anaemia. Since then, additional essential trace elements have been discovered. Deficiency or imbalance, whether occurring naturally or from human activities, has been shown to present significant problems for the health of man and animals. Essentiality has been proved for a rapidly growing range of 'new' trace elements, whose biochemical mechanisms of action and implications for human health are unknown. In spite of an increasing knowledge of significant changes in the exposure of man and animals to trace elements from diet and environment, the concern of nutrition policy planners for inorganic micro-nutrients remains overshadowed by that for the bulk components of the diet. The application of existing knowledge of trace element nutrition to problems of human and animal health will depend on a clear understanding of events that link molecular, biochemical mechanisms to the clinical manifestation of deficiencies.     

The future of the brain

In only the past few decades, neuroscience has expanded beyond recognition, and shows no sign of slowing down. The problems for this ever-growing and increasingly fragmented field are matched only by its potentials. This article explores possible avenues of research and ethical debate that wait to be faced in the new Decade of the Mind.     

The importance of long‐term social‐ecological research for the future of restoration ecology

In the face of rapid environmental and cultural change, long‐term ecological research (LTER) and social‐ecological research (LTSER) are more important than ever. LTER contributes disproportionately to ecology and policy, evidenced by the greater proportion of LTER in higher impact journals and the disproportionate representation of LTER in reports informing policymaking. Historical evidence has played a significant role in restoration projects and it will continue to guide restoration into the future, but its use is often hampered by lack of information, leading to considerable uncertainties. By facilitating the storage and retrieval of historical information, LTSER will prove valuable for future restoration.     

The importance and future of biochemical engineering

Today's Biochemical Engineer may contribute to advances in a wide range of technical areas. The recent Biochemical and Molecular Engineering XXI conference focused on “The Next Generation of Biochemical and Molecular Engineering: The role of emerging technologies in tomorrow's products and processes”. On the basis of topical discussions at this conference, this perspective synthesizes one vision on where investment in research areas is needed for biotechnology to continue contributing to some of the world's grand challenges.     

Biotechnology, the brain and the future

Several new approaches to illness, inspired by recent advances in molecular biology, informatics and nanoscience, are readily applicable to diseases of the central nervous system. Novel classes of drugs will widen the scope of therapeutic action beyond merely modifying transmitter function and stem cell and gene therapies could offer an even more selective mode of targeting. Further into the future, nanotechnology has the potential to allow development of new medicines and novel access routes via miniaturized monitoring and screening devices: these systems, together with increasing use of carbon-silicon interfacing, will challenge traditional neuropharmacology. As the 21(st) century unfolds, the structure and function of the brain, which is incomparable with any other organ, will present unique technological and ethical questions.     

The importance of scientific collecting and natural history museums for comparative neuroanatomy

The comparative study of vertebrate brains is inherently dependent upon access to a sufficient number of species and specimens to perform meaningful comparisons. Although many studies rely on compiling published information, continued specimen collection, in addition to more extensive use of existing brain collections and natural history museums, are crucial for detailed neuroanatomical comparisons across species. This review highlights the importance of collecting species through a variety of means, details a marsupial brain collection, and stresses the potential of natural history museums as a resource for comparative neuroanatomy. By taking advantage of as many of these resources as possible, researchers can rapidly increase species coverage and generate a better understanding of how the brain evolves.     

Recent advances and future prospects in peptaibiotics, hydrophobin, and mycotoxin research, and their importance for chemotaxonomy of Trichoderma and Hypocrea

Fungi of the genus Trichoderma with teleomorphs in Hypocrea are abundant producers of a group of amphiphilic, non-ribosomal peptide antibiotics, which are rich in the non-proteinogenic amino acid Aib (alpha-aminoisobutyric acid). They are referred to as peptaibiotics, or peptaibols, if a 1,2-amino alcohol is present at the C-terminus. Trichoderma/Hypocrea, like other ascomycetous fungi, also produce hydrophobins, a class of small, cysteine-rich proteins. Advanced soft ionization mass spectrometric techniques such as LC-CID-MS, LC-ESI-MS(n), and IC-MALDI-TOF-MS enabled the high-throughput analysis, simultaneous detection and sequence determination of peptaibiotics and hydrophobins from minute quantities of fungal materials. Some Trichoderma species have been recognized to produce peptaibiotics as well as simple mycotoxins of the trichothecene group. The combination of sequence data of both groups of peptides with the pattern of low-molecular-weight secondary metabolites, including trichothecene-type mycotoxins, independently confirmed the results of morphological, molecular, and phylogenetic analyses. This approach established a new lineage in Trichoderma/Hypocrea, the Brevicompactum clade, comprising four new and one redescribed species. Notably, commercial preparations of single or mixed cultures of Trichoderma species, in particular T. harzianum, and T. koningii, are registered as biocontrol agents for soil and plant pathogens. In this context, it is emphasized that the four mycotoxin-producing species of the recently established Brevicompactum clade (T. brevicompactum, T. arundinaceum, T. turrialbense, and T. protrudens) are not closely related to any of the Trichoderma species currently used as biocontrol agents. Furthermore, possible health concerns about release of peptaibiotics in the biosphere are discussed with respect to their bioactivities and their use as drugs in human and veterinary medicine. Finally, future prospects regarding novel bioactivities and further research needs, including interdisciplinary taxonomic approaches, are outlined.